Integra LifeSciences Holdings Corporation IART
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.01M | -7.24M | -495.80M | -516.47M | -495.34M |
| Total Depreciation and Amortization | 154.06M | 153.52M | 153.07M | 151.83M | 158.09M |
| Total Amortization of Deferred Charges | 4.10M | 4.35M | 5.22M | 5.61M | 5.99M |
| Total Other Non-Cash Items | 4.14M | -17.49M | 448.66M | 443.16M | 450.94M |
| Change in Net Operating Assets | -34.91M | -47.80M | -39.71M | -33.74M | -30.38M |
| Cash from Operations | 140.40M | 85.33M | 71.44M | 50.38M | 89.31M |
| Capital Expenditure | -54.62M | -59.53M | -67.36M | -81.44M | -93.82M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 4.18M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.67M | -49.10M | -19.63M | -26.63M | 12.23M |
| Cash from Investing | -103.28M | -108.63M | -86.99M | -108.06M | -77.41M |
| Total Debt Issued | 145.50M | 729.30M | 710.80M | 720.70M | 706.40M |
| Total Debt Repaid | -151.55M | -699.23M | -690.23M | -669.89M | -684.75M |
| Issuance of Common Stock | 760.00K | 760.00K | 760.00K | 957.00K | 957.00K |
| Repurchase of Common Stock | -1.93M | -1.93M | -2.16M | -2.92M | -5.39M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.25M | -7.33M | -17.92M | -20.52M | -20.38M |
| Cash from Financing | -14.47M | 21.58M | 1.26M | 28.34M | -3.16M |
| Foreign Exchange rate Adjustments | -2.57M | -1.78M | 12.00M | 18.02M | 8.28M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.08M | -3.50M | -2.30M | -11.33M | 17.03M |